graduation at Biomedicina from Universidade Franciscana (2015) and master's at Biotecnologia from Universidade Estadual Paulista Júlio de Mesquita Filho (2018). Has experience in Immunology, acting on the following subjects: nanotecnologia, biocompatibilidade, vacinas, toxicidade and citotoxicidade. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Breast Cancer is the second most common Cancer in incidence and mortality among females and according to national and international health organizations, this number has increased in recent years. The development of new therapies for the treatment of Cancer is necessary because of this increasing number of cases and the difficulty of effective treatments. Among the molecular mechanisms in…
Colorectal cancer (CRC) is the third most prevalent type of cancer worldwide and frequently associated with metastatic complications. Therapeutic strategies used to treat those patients who do not respond to conventional chemotherapy is based on the application of monoclonal antibodies cetuximab or panitumumab, both directed to the epidermal growth factor receptor (EGFR). However, in some…
| 2 / 2 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID